Veliparib Plus Temozolomide Does Not Affect Survival in Metastatic Melanoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Annals of Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Randomized Phase 2 Study Evaluating Veliparib (ABT-888) With Temozolomide in Patients With Metastatic Melanoma
Ann. Oncol 2015 Jul 22;[EPub Ahead of Print], MR Middleton, P Friedlander, O Hamid, A Daud, R Plummer, N Falotico, B Chyla, F Jiang, E McKeegan, NM Mostafa, M Zhu, J Qian, M McKee, Y Luo, VL Giranda, GA McArthurFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.